Skip to main content

Table 2 Transition of clinical parameters in patients with ICI-induced hypopituitarism

From: Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma

 

Baseline

Last visit

Onset

p-value

WBC count (/µL)

6805 ± 1359

6698 ± 1253

6905 ± 1076

0.919

Neutrophil count (/µL)

4903 ± 1121

4295 ± 1291

4022 ± 874

0.153

Lymphocyte count (/µL)

1294 ± 474

1560 ± 371

1738 ± 531

0.076

Eosinophil count (/µL)

99 [74–177]

389 ± 261

588 ± 304

 < 0.001

Sodium level (mmol/L)

139 ± 2.1

139 ± 3.1

137.5 [135–138]

0.056

Potassium level (mmol/L)

4.58 ± 0.33

4.42 ± 0.42

4.29 ± 0.28

0.148

Glucose level (mg/dL)

118 ± 27

124 ± 35

95 [82–106]

0.059

Blood urea nitrogen level (mg/dL)

17.2 ± 3.5

20.5 ± 3.5

18.9 ± 6.9

0.265

Creatinine level (mg/dL)

0.93 [0.86–1.00]

1.15 ± 0.26

1.15 [1.07–1.32]

0.184

Hyponatremia, n

0

2

3

0.247

Hyperkalemia

0

0

0

1.000

Hypoglycemia, n

0

0

2

0.135

Hypereosinophilia, n

0

4

5

0.015

  1. Data were expressed as means ± standard deviation, and skewed variables as medians with interquartile ranges
  2. WBC white blood cell